9-hydroxy-4-androstene-3,17-dione: structure given in first source; RN given refers to parent compound
9alpha-hydroxyandrost-4-en-3,17-dione : A 3-oxo-Delta(4)-steroid that is androst-4-ene substituted by oxo groups at positions 3 and 17 and a hydroxy group at position 9.
ID Source | ID |
---|---|
PubMed CID | 10425017 |
CHEBI ID | 85549 |
SCHEMBL ID | 330191 |
MeSH ID | M0206234 |
Synonym |
---|
9alpha-hydroxy-4-androstene-3,17-dione |
C1030 |
9alpha-hydroxyandrostenedione |
560-62-3 |
(8s,10s,13s,14s)-9-hydroxy-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione |
9alpha-hydroxyandrost-4-ene-3,17-dione |
androst-4-ene-3,17-dione, 9-hydroxy- |
ec 611-349-9 |
9-hydroxy-4-androstene-3,17-dione |
9-oh-ad |
bdbm91716 |
11alpha-hydroxyandrost-4-en-3,17-dione, 5 |
SCHEMBL330191 |
9alpha-hydroxy-androst-4ene-3,17-dione |
SNMVJSSWZSJOGL-PLOWYNNNSA-N |
9alpha-hydroxy-androst-4-en-3,17-dione |
9alpha-hydroxy-androstenedione |
9-hydroxyandrost-4-ene-3,17-dione |
9alpha-hydroxyandrost-4-en-3,17-dione |
9alpha-hydroxy-androst-4-ene-3,17-dione |
CHEBI:85549 |
AKOS027430332 |
Q27158635 |
(8s,9r,10s,13s,14s)-9-hydroxy-10,13-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione |
(8s,9r,10s,13s,14s)-9-hydroxy-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1h-cyclopenta[a]phenanthrene-3,17(2h,6h)-dione |
A929586 |
CS-0094080 |
DTXSID401336076 |
F88008 |
Class | Description |
---|---|
3-oxo-Delta(4) steroid | A 3-oxo steroid conjugated to a C=C double bond at the alpha,beta position. |
17-oxo steroid | Any oxo steroid carrying the oxo group at position 17. |
9-hydroxy steroid | A hydroxy steroid having a hydroxy group located at position 9. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Cholinesterase | Homo sapiens (human) | IC50 (µMol) | 141.2800 | 0.0000 | 1.5599 | 10.0000 | AID1799735 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
xenobiotic metabolic process | Cholinesterase | Homo sapiens (human) |
learning | Cholinesterase | Homo sapiens (human) |
negative regulation of cell population proliferation | Cholinesterase | Homo sapiens (human) |
neuroblast differentiation | Cholinesterase | Homo sapiens (human) |
peptide hormone processing | Cholinesterase | Homo sapiens (human) |
response to alkaloid | Cholinesterase | Homo sapiens (human) |
cocaine metabolic process | Cholinesterase | Homo sapiens (human) |
negative regulation of synaptic transmission | Cholinesterase | Homo sapiens (human) |
response to glucocorticoid | Cholinesterase | Homo sapiens (human) |
response to folic acid | Cholinesterase | Homo sapiens (human) |
choline metabolic process | Cholinesterase | Homo sapiens (human) |
acetylcholine catabolic process | Cholinesterase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
amyloid-beta binding | Cholinesterase | Homo sapiens (human) |
catalytic activity | Cholinesterase | Homo sapiens (human) |
acetylcholinesterase activity | Cholinesterase | Homo sapiens (human) |
cholinesterase activity | Cholinesterase | Homo sapiens (human) |
protein binding | Cholinesterase | Homo sapiens (human) |
hydrolase activity, acting on ester bonds | Cholinesterase | Homo sapiens (human) |
enzyme binding | Cholinesterase | Homo sapiens (human) |
choline binding | Cholinesterase | Homo sapiens (human) |
identical protein binding | Cholinesterase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
extracellular region | Cholinesterase | Homo sapiens (human) |
nuclear envelope lumen | Cholinesterase | Homo sapiens (human) |
endoplasmic reticulum lumen | Cholinesterase | Homo sapiens (human) |
blood microparticle | Cholinesterase | Homo sapiens (human) |
plasma membrane | Cholinesterase | Homo sapiens (human) |
extracellular space | Cholinesterase | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1799735 | Cholinesterase Inhibition Assay from Article 10.1080/14756360802236393: \\Butyrylcholinesterase inhibitory activity of testosterone and some of its metabolites.\\ | 2009 | Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 24, Issue:2 | Butyrylcholinesterase inhibitory activity of testosterone and some of its metabolites. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 8 (61.54) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 13 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |